#154042

Anti-F. tularensis LVS sucC [121]

Cat. #154042

Anti-F. tularensis LVS sucC [121]

Cat. #: 154042

Unit size: 100 ug

Target: Succinyl coA synthetase, beta subunit (sucC)

Class: Monoclonal

Application: ELISA ; IF ; IP ; WB

Reactivity: Francisella tularensis

Host: Mouse

£300.00

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Contributor

Inventor: Anne Savitt

Institute: Stony Brook University

Tool Details
Target Details
Applications
Handling
References

Tool Details

*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)

  • Name: Anti-F. tularensis LVS sucC [121]
  • Research fields: Microbiology
  • Class: Monoclonal
  • Conjugation: Unconjugated
  • Molecular weight: 40 kDa
  • Reactivity: Francisella tularensis
  • Host: Mouse
  • Application: ELISA ; IF ; IP ; WB
  • Description: This mouse IgG2a monoclonal antibody is reactive against both F. tularensis LVS and F. tularensis SchuS4 protein Succinyl coA synthetase, beta subunit (sucC) (does not react with but not F. novicida). Francisella tularensis is a small pathogenic gram-negative bacterium that causes tularemia.
  • Immunogen: Sublethal infection with F. tularensis LVS
  • Isotype: IgG2a

Target Details

  • Target: Succinyl coA synthetase, beta subunit (sucC)
  • Molecular weight: 40 kDa
  • Target background: This mouse IgG2a monoclonal antibody is reactive against both F. tularensis LVS and F. tularensis SchuS4 protein Succinyl coA synthetase, beta subunit (sucC) (does not react with but not F. novicida). Francisella tularensis is a small pathogenic gram-negative bacterium that causes tularemia.

Applications

  • Application: ELISA ; IF ; IP ; WB

Handling

  • Format: Liquid
  • Unit size: 100 ug
  • Shipping conditions: Shipping at 4° C

References

  • Savitt et al. 2009. Clin Vaccine Immunol. 16(3):414-22. PMID: 19176692.
  • Francisella tularensis infection-derived monoclonal antibodies provide detection, protection, and therapy.